IMNOVID Trademark

Trademark Overview


On Thursday, January 19, 2017, a trademark application was filed for IMNOVID with the United States Patent and Trademark Office. The USPTO has given the IMNOVID trademark a serial number of 87307332. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 5, 2024. This trademark is owned by Celgene Corporation. The IMNOVID trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations for the treatment of certain cancers, blood diseases and immune-related diseases and printed dosage instructional manuals sold together as a unit
imnovid

General Information


Serial Number87307332
Word MarkIMNOVID
Filing DateThursday, January 19, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 5, 2024
Registration Number5294703
Registration DateTuesday, September 26, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 11, 2017

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations for the treatment of certain cancers, blood diseases and immune-related diseases and printed dosage instructional manuals sold together as a unit
Translation of Words in MarkThe wording "IMNOVID" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 5, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events


Event DateEvent Description
Monday, January 23, 2017NEW APPLICATION ENTERED
Thursday, January 26, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 18, 2017NON-FINAL ACTION WRITTEN
Wednesday, April 19, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 27, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 27, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 30, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 16, 2017TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, March 2, 2017ASSIGNED TO LIE
Wednesday, March 8, 2017PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Friday, April 14, 2017ASSIGNED TO EXAMINER
Tuesday, April 18, 2017NON-FINAL ACTION E-MAILED
Tuesday, April 18, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 21, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 11, 2017PUBLISHED FOR OPPOSITION
Tuesday, July 11, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 26, 2017REGISTERED-PRINCIPAL REGISTER
Monday, September 26, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, December 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, June 5, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, December 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, December 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 9, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, April 5, 2024CANCELLED SEC. 8 (6-YR)